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PURPOSE. Recessive mutations in CLN7/MFSD8 usually cause variant late-infantile onset
neuronal ceroid lipofuscinosis (vLINCL), a poorly understood neurodegenerative condition,
though mutations may also cause nonsyndromic maculopathy. A series of 12 patients with
nonsyndromic retinopathy due to novel CLN7/MFSD8 mutation combinations were
investigated in this study.
METHODS. Affected patients and their family members were recruited in ophthalmic clinics at
each center where they were examined by retinal imaging and detailed electrophysiology.
Whole exome or genome next generation sequencing was performed on genomic DNA from
at least one affected family member. Immunofluorescence confocal microscopy of murine
retina cross-sections were used to localize the protein.
RESULTS. Compound heterozygous alleles were identified in six cases, one of which was
always p.Glu336Gln. Such combinations resulted in isolated macular disease. Six further cases
were homozygous for the variant p.Met454Thr, identified as a founder mutation of South
Asian origin. Those patients had widespread generalized retinal disease, characterized by
electroretinography as a rod-cone dystrophy with severe macular involvement. In addition,
the photopic single flash electroretinograms demonstrated a reduced b- to a-wave amplitude
ratio, suggesting dysfunction occurring after phototransduction. Immunohistology identified
MFSD8 in the outer plexiform layer of the retina, a site rich in photoreceptor synapses.
CONCLUSIONS. This study highlights a hierarchy of MFSD8 variant severity, predicting three
consequences of mutation: (1) nonsyndromic localized maculopathy, (2) nonsyndromic
widespread retinopathy, or (3) syndromic neurological disease. The data also shed light on the
underlying pathogenesis by implicating the photoreceptor synaptic terminals as the major site
of retinal disease.
Keywords: macular degeneration, retinal dystrophy, DNA sequencing, electroretinography,
immunohistology, photoreceptor synapse
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Inherited retinal dystrophies (IRD) are a complex group ofgenetically heterogeneous eye disorders that are caused by
Mendelian mutations in over 200 genes (see https://sph.uth.
edu/retnet/; provided in the public domain by The University
of Texas Health Science Center, Houston, TX, USA). They are
initially diagnosed according to the patient’s clinical symptoms,
their age of onset, and the cell type that is primarily affected by
the condition. Knowledge of the underlying genetic defect
allows for a more comprehensive description, though the
assumption that each genetic disorder may have a unique
clinical signature is oversimplified since molecular screening
has revealed profound heterogeneity, both clinical and genetic,
in inherited retinal diseases. Additionally, we are now starting
to appreciate that isolated retinal disease can be associated
with variants in genes previously identified as only causing
syndromic disease.1
The neuronal ceroid lipofuscinoses (NCLs) are a group of
lysosomal storage disorders resulting from single gene defects
in lysosomal hydrolases or lysosomal/endoplasmic reticulum
membrane proteins.2 They are characterized by early onset
neurodegeneration associated with accumulation of autofluor-
escent intracellular inclusions in neurons and extraneuronal
tissues.3 Collectively, they are the most common cause of
childhood neurodegenerative disease. Initially classified using
clinical and electron microscopic features, the NCLs are now
defined primarily by their genetic basis. At least 13 genetic
forms are currently recognized (CLN1–8 and CLN10–14); with
the exception of CLN4 disease, all are recessively inherited.
Mutations in the major facilitator superfamily (MFS) domain-
containing protein 8 (MFSD8/CLN7, MIM 611124) were found
to cause a variant of late-infantile NCL (vLINCL, MIM
610951).4–8 Symptoms of vLINCL usually start between the
ages of 3 and 6 years, with seizures and developmental
regression followed by speech failure, ataxia, visual loss,
myoclonus, and ultimately premature death. Recently, reces-
sive mutations in MFSD8 have also been associated with
nonsyndromic macular dystrophy in two families.9 Retinal
dysfunction in the absence of syndromic association had not
previously been reported. Despite many advances in NCL
research, the biological basis for neurodegeneration remains
elusive. The present study provides novel mechanistic insights
gleaned from detailed phenotypic investigations in 12 patients
with MFSD8-associated retinopathy, together with immunolo-
calization studies in the murine retina. Possible genotype–
phenotype correlations underlying nonsyndromic and syn-
dromic disease are also discussed.
MATERIALS AND METHODS
Patient Ascertainment and Clinical Evaluation
The study was approved by the appropriate local research
ethics committees and the protocol adhered to the tenets of
the Declaration of Helsinki. Patients were ascertained from the
inherited eye disease clinics at Moorfields Eye Hospital, London
(Patients GC19741, GC17967, GC14328, GC18458, GC19832,
GC3716, and GC4694), Bradford Royal Infirmary, Bradford
(Patient LE1), St. James’s University Hospital, Leeds (Patients
LE2 and LE3), Casey Eye Institute, Portland (CEI1), and Wilmer
Eye Institute, Baltimore (CEI2). A diagnosis of inherited retinal
disease was made by an experienced ophthalmologist based on
signs and symptoms, including progressive and symmetrical
retinal disease.
Detailed clinical investigations included best-corrected
visual acuity (VA; Snellen chart), confrontation visual fields,
and pattern and full-field electroretinography (PERG, ERG)
using techniques that incorporated the International Society of
Clinical Electrophysiology of Vision (ISCEV) recommenda-
tions.10,11 Retinal imaging was performed using color fundus
photography (Topcon TRC 50IA retinal camera, Topcon Corp.,
Tokyo, Japan), spectral-domain optical coherence tomography
(Spectralis HRAþOCT, Heidelberg Engineering, Heidelberg,
Germany), and 488-nm wavelength fundus autofluorescence
(AF) with either a 308 or 558 field (Spectralis HRAþOCT,
Heidelberg Engineering).
Molecular Genetic Analysis
Genomic DNA from affected patients was extracted and
analyzed either by whole exome (SureSelect All Exon XT
Sequencing kit, Agilent Technologies, Santa Clara, CA, USA) or
by whole genome sequencing (Illumina TruSeq DNA PCR-free
sample preparation kit, Illumina, San Diego, CA, USA, followed
by Illumina HiSeq 2500 sequencing as part of the NIHR
BioResource–Rare Diseases project) according to the manufac-
turer’s instructions. FastQ files were aligned to the GRCh37
(hg19) reference genome. Potentially pathogenic variants were
identified, filtered based on functionality, minor allele frequen-
cy (MAF) in public and in-house databases, and on calculated
pathogenicity scores. Putative mutations were validated by
Sanger sequencing and checked for segregation.
Immunofluorescence and Confocal Microscopy
Sagittal sections from the eyes of 30-day-old mice were
incubated with goat polyclonal anti-MFSD8 (S-14; Santa Cruz
Biotechnology, Heidelberg, Germany), followed by an Alexa
Fluor 568-conjugated donkey anti-goat immunoglobulin (Mo-
lecular Probes, Inc., Eugene, OR, USA). Nuclei were counter-
stained with DAPI (Vector Laboratories, Orton Southgate, UK).
As controls, a section was stained with secondary and another
was treated with primary antibody that had been preincubated
with peptide antigen followed by secondary. For the co-
localization experiments, sections were incubated with anti-
MFSD8 and either rabbit polyclonal anti-SNAP-25 (ab5666;
Abcam, Cambridge, UK) or rabbit polyclonal anti-PSD-95
(ab18258; Abcam) followed by Alexa Fluor 568-conjugated
donkey anti-goat immunoglobulin and Alexa Fluor 488-
conjugated chicken anti-rabbit immunoglobulin (Molecular
Probes, Inc.), and counterstained with DAPI. Confocal images
were obtained using an Eclipse TE2000-E system microscope
(Nikon Corp., Tokyo, Japan) and processed using Nikon EZ-C1
3.50 software.
RESULTS
Molecular Analysis
Nine families were identified by next generation sequencing of
genomic DNA from patients with nonsyndromic retinal
dystrophy, which included 12 individuals carrying biallelic
variants in MFSD8 (Fig. 1). Six of the cases (GC19741, LE1–
LE3, CEI1, and CEI2) were compound heterozygotes that
carried the variant, c.1006G>C, p.Glu336Gln, paired with one
of three other disease-causing alleles. This allele was identified
in trans with a null variant (c.103C>T, p.Arg35Ter for
GC19741 or c.233G>A, p.Trp78Ter for CEI1 and CEI2) or a
missense change (c.1394G>A, p.Arg465Gln for LE1–LE3). The
remaining six cases (GC17967, GC14328, GC18458, GC19832,
GC3716, and GC4694) were homozygous for the missense
variant, c.1361T>C, p.Met454Thr. Three of these individuals
(GC17967, GC14328, and GC3716) were the offspring of three
separate consanguineous marriages. A common shared founder
haplotype of South Asian origin, spanning approximately 1.47
Mb was identified by examining single nucleotide variants in
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the WGS data at the MFSD8 locus from four cases with the
homozygous variant c.1361T>C (Supplementary Table S1).
The variants were found to co-segregate with the disease in all
family members from whom DNA was available (Fig. 1).
Clinical Investigations
The clinical features of the 12 cases are summarized in the
Table. Central visual loss was the primary complaint in all
patients. Patients with isolated maculopathy (GC19741, LE1–
LE3, CEI1, and CEI2) developed symptoms at a later age than
those with generalized retinopathy (GC17967, GC14328,
GC18458, GC19832, GC3716, and GC4694). Patients with a
compound heterozygous genotype that included c.1006G>C,
p.Glu336Gln had isolated macular disease. In contrast, cases
with a homozygous c.1361T>C, p.Met454Thr genotype had
more widespread retinopathy, with the majority also reporting
night-blindness. No signs or symptoms of neurological disease
were apparent. Fundus examination findings ranged from
minimal changes (GC19741) to those typical of advanced
retinitis pigmentosa (GC3716; Fig. 2A). Corresponding struc-
tural changes were present in all cases when imaged using AF
and optical coherence tomography (OCT; Figs. 2B, 2C).
Patients with clinically isolated macular disease (CEI1 and
GC19741) initially showed only pattern ERG abnormalities,
though as the disease progressed the full field ERG could
become abnormal, with the photopic single flash ERG (CEI1)
showing a disproportionate loss of b- to a-wave leading to a
significantly reduced b- to a-wave ratio (Fig. 3). Patients with
peripheral retinal signs (GC17967 and GC14328) also had
highly abnormal full-field ERGs, in keeping with a severe rod-
cone dystrophy with marked macular involvement (Fig. 3). The
photopic single flash ERGs (GC17967 and GC14328) again
showed reduction in the b to a amplitude ratio. Although there
was a lower amplitude b-wave than a-wave in the bright flash
dark-adapted ERG, that is likely to be a reflection of a cone
isolated retina, with all signals arising from dark-adapted cones,
rather than inner retinal dysfunction with the rod system.
CLN7/MFSD8 Localization in the Retina
Confocal immunofluorescence microscopy in the murine
retina showed that MFSD8 predominantly localized to the
outer plexiform layer (OPL), a region rich in synaptic
connections between photoreceptors and second order
neurons—bipolar and horizontal cells (Fig. 4). Co-localization
studies highlighted considerable overlap in the staining pattern
for MFSD8 localization and PSD-95, but not SNAP-25, suggest-
ing that MFSD8 is predominantly located at the photoreceptor
synaptic terminals rather than bipolar or horizontal cells.
DISCUSSION
Mutations in MFSD8 usually cause vLINCL, a severe, early-onset
neurodegeneration characterized by seizures, progressive
mental and motor deterioration, myoclonus, visual failure,
and ultimately premature death.4–8,14–19 Atypical presentations
also exist, either commencing at a later age associated with
mild disease,7 or a recently described, nonsyndromic form
causing only macular disease.9 The present study describes a
fourth consequence of MFSD8 dysfunction: widespread rod-
cone dystrophy with severe macular involvement. Longitudinal
study is needed to determine whether patients with isolated
retinal disease eventually develop neurological involvement,
FIGURE 1. Families and case subjects reported in this study and MFSD8
mutation data. The affected patients (shaded black) who were
examined are shown with their identification code (GC19741,
GC17967, GC14328, GC18458, GC19832, GC3716, GC4694, LE1–
LE3, CEI1, and CEI2). The genotypes for all subjects tested are shown
below each individual, with M representing the mutant allele as shown
and þ representing the wild-type allele.
FIGURE 2. Retinal images of patients with nonsyndromic retinal
dystrophy caused by biallelic MFSD8 mutations. Color fundus
photographs (CFPs) (A), 488-nm fundus autofluorescence (FAF) images
(B), and macular OCT scans (C) from patients GC19741, LE3, CEI1,
GC17967, GC14328, GC18458, GC3716, and a normal control subject.
GC19741 and CEI1 have disease that is localized to the fovea, with
minimal if any signs visible on CFPs. The subtle increase in foveal AF
correlates with the outer retinal cavitation on OCT suggesting focal loss
of photoreceptors. LE3 manifests a more severe maculopathy.
GC17967, GC14328, GC18458, and GC3716 show more extensive
disease typical of retinitis pigmentosa with severe macular involve-
ment. Imaging shows pigment migration into the retina and arteriolar
attenuation (CFP), and loss of physiological AF, consistent with
extensive degeneration of the outer retinal structures (FAF and OCT).
GC14328 additionally manifests a ring of increased AF demarcating the
central boundary between normal and abnormal retina; in GC3716 the
atrophy is so advanced that choroidal vessel AF is visible.
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FIGURE 3. ERG and PERG of four patients (CEI1, GC19741, GC17967, and GC14328) and a normal subject. The ages of the subjects at examination
are shown. The ISCEV standard ERGs, with conventional nomenclature, are shown. DA, dark-adapted; LA, light-adapted. The subsequent number
indicates flash strength in cd.s.m2. All are single flash responses other than the LA 30-Hz response, which uses computerized signal averaging. Blink
artefact in CEI1 (at 49 and 54 years), GC17967 (at 43 years), and GC14328 has been replaced by broken lines. CEI1 and GC19741, who have a
macular dystrophy phenotype, show normal full-field ERGs (for initial CEI1 and GC19741 recordings) but a subnormal PERG (when available). The
later recording of CEI1 shows a normal dark-adapted response but a reduced b- to a-wave ratio in the LA 3.0 response in keeping with a progressive
loss of inner retinal cone function. The initial recordings of GC17967 show marked loss of rod system function with generalized cone system
dysfunction. The DA 0.01 response is undetectable, the DA 10.0 shows a markedly abnormal a-wave in keeping with photoreceptor dysfunction, LA
3.0 30 Hz and LA 3.0 are subnormal and markedly delayed, and the PERG is detectable but subnormal. These findings indicate a rod-cone dystrophy
with relatively mild macular involvement. Later recordings show an undetectable PERG in keeping with worsening macular function, and all
detectable ERGs show profound deterioration. GC14328 and the later recordings of GC17967 show a lower b- than a-wave in the DA 10.0 response
suggesting a dark-adapted cone origin with all rod function having been lost. The photopic ERGs are subnormal and delayed, but over time there is
the development of a broadened a-wave in the LA 3.0 response with marked reduction in the b to a ratio in keeping with additional inner retinal
cone system dysfunction. The recordings from a normal control subject are included for comparison.
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though it is reassuring that the three oldest patients reported
herein developed no neurological abnormalities despite being
in their seventh or eighth decade of life.
ERG localizes the consequences of MFSD8 dysfunction
more precisely. The scotopic bright flash ERG is a mixed rod-
cone response, dominated by the rod-system. Most of the
negative going a-wave reflects photoreceptor hyperpolariza-
tion, with the later positive going b-wave generated in the
bipolar cells. The photopic single flash ERG a-wave is
generated by cone photoreceptors and Off-(hyperpolarizing)
bipolar cells, with the positive b-wave being an effectively
synchronized response from On- and Off-bipolar cells. Those
patients homozygous for the p.Met454Thr allele demonstrated
a reduction in the photopic b to a ratio, a feature not typically
associated with primary photoreceptor degeneration. Al-
though a reduced b- to a-wave ratio can occur in the bright
flash dark-adapted ERG in cone isolated retinas due to vitamin
A deficiency,20 or RDH5 mutation,21 when rod loss is so severe
that all remaining signals arise in dark-adapted cones, the
photopic ERGs do not exhibit such a phenomenon. The
reduced photopic b to a ratio in the present series thus
indicates dysfunction after phototransduction beyond the
photoreceptor outer segment. This contention is further
supported in a patient carrying the p.Glu336Gln variant allele,
who has isolated macular disease but developed a reduced
photopic ERG b- to a-wave ratio over a 6-year period, indicating
progressive ‘‘inner retinal’’ cone dysfunction. Immunofluores-
cence of the murine retinal sections demonstrated that the
strongest MFSD8 signal arises in the OPL, in the photoreceptor
synaptic terminals, in keeping with the electrophysiological
data.
Thus two independent lines of evidence implicate the OPL
in MFSD8-associated retinal disease. The localization of MFSD8
to the photoreceptor presynaptic terminals, together with the
presence of a post-phototransduction ERG abnormality in
patients with MFSD8 mutations, strongly suggests a synaptic
origin for the defect. Synaptic alterations have previously been
suggested as initiating events causing NCL in the CLN5-
knockout sheep22 and in a mouse model of lysosomal disease
due to a defect in cathepsin D function (CLN10).23
Overall, the data suggest that macular photoreceptors
appear to be most sensitive to mutations in MFSD8.
Extramacular photoreceptors are the next most vulnerable,
with cortical neurons being the most resistant of the affected
cell types. There are anatomical and physiological differences
between photoreceptor and conventional synapses that could
account for this differential vulnerability. Photoreceptor
terminals release neurotransmitter continuously, with light
turning off vesicle release, whereas cortical neurons are usually
switched off and are only triggered by action potentials. To
permit these unique properties of photoreceptors, the
terminals contain many more synaptic vesicles of which
~85% are freely mobile, actively participating in glutamate
release, compared to ~20% in conventional synapses.24–27
Furthermore, photoreceptor termini possess a synaptic ribbon
for vesicle docking, necessary for maintaining the higher rates
of neurotransmitter release over a sustained period of time.28 It
is also relevant that peripheral cones contain twice as many
ribbons as central cones,29 suggesting that this, or a similar
synaptic modification, may underlie the different photorecep-
tor sensitivities.
To date, MFSD8 has been shown to be a lysosomal
membrane protein with an MFS transporter domain that is
characteristic of proteins that transport small solutes through
chemiosmotic ion gradients.30 The substrates for MFSD8 are
unknown. However, as MFSD8 predominantly localizes to
photoreceptor synaptic terminals in the retina, it could be
speculated that it may form part of the synaptic vesicles. The
consequences of MFSD8 mutation may be synaptic dysfunction
resulting in disordered neurotransmitter release and local
excitotoxicity. This may lead to downstream secondary
consequences that have been described such as the accumu-
lation of aggregate storage material in neuronal cells,5,16,31,32
impaired autophagy,33 and cell death, as well as accompanying
inflammation that occurs both in the brains of MFSD8-deficient
patients31 and in the MFSD8-knockout dog34 and mouse
models.33,35
All previously published MFSD8 mutation combinations
associated with disease are listed at http://www.ucl.ac.uk/ncl/
FIGURE 4. Localization of MFSD8 to the OPL. Immunofluorescence
photomicrographs of mouse retinal sagittal sections stained with anti-
MFSD8 only (A), or combined with anti-PSD-95 (B) or anti-SNAP-25 (C)
and Alexa Fluor 568-conjugated secondary antibody (red) or Alexa
Fluor 488-conjugated secondary antibody (green) and DAPI nuclear
counterstain (blue) are shown. The secondary antibody alone or anti-
MFSD8 preincubated with peptide were incubated with different serial
sections as controls in the experiment. The images shown in B and C
are separate and merged channels of the same section. The layers of the
retina are depicted; retinal pigment epithelium (RPE), photoreceptor
layer (PL), outer nuclear layer (ONL), OPL, inner nuclear layer (INL),
inner plexiform layer (IPL), and the ganglion cell layer (GCL) are
shown. Scale bar represents 50 lm. Note that MFSD8 staining
predominantly co-localizes with PSD-95, a known marker for presyn-
aptic photoreceptor terminals.12 SNAP-25 localizes to horizontal cells
at the OPL.13
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CLN7patienttable.htm (provided in the public domain by the
University College London, UK). The previously described
p.Glu336Gln substitution, which gives rise to a ‘‘mild’’ variant
allele, causes isolated macular dystrophy when paired either
with a null variant on the other allele9 or a missense variant
(p.Arg465Gln) as shown here. In direct contrast, the
p.Arg465Gln variant, when paired with a null allele, causes
vLINCL rather than isolated retinal disease.14 The other allele
of interest, p.Met454Thr, may be considered a ‘‘moderate’’
allele since homozygous variants cause a more severe rod-cone
dystrophy but not vLINCL. The severe neurological phenotype
may only occur when the p.Met454Thr variant is paired with a
more severe allele.17 In addition, an atypical patient with late-
onset vLINCL was homozygous for the p.Ala157Pro missense
variant, suggesting that allele may be hypomorphic, accounting
for the less severe phenotype.7 All other reported cases with
homozygous missense alleles cause vLINCL. A study that
overexpressed two vLINCL-causing missense mutations,
p.Thr294Lys and p.Pro412Leu, found enhanced proteolytic
cleavage of mutant MFSD8 by cysteine proteases, inactivating
the protein. It was suggested that some of the missense alleles
may represent functional null mutations.36 Based on the
pathogenicity prediction scores of the missense mutations
(Supplementary Table S2) and the topology prediction diagram
that maps the mutations on the protein sequence (Fig. 5) there
appears to be no obvious correlation between the mutations
and whether the patient develops vLINCL or nonsyndromic
eye disease. The missense changes, p.Glu336Gln and
p.Met454Thr, that are associated with nonsyndromic eye
disease may disrupt normal protein function either by reducing
the transporter function of MFSD8 or by abrogating a yet to be
defined specific function that is unique to photoreceptor
synapses, but absent from conventional synapses.
To conclude, this study describes patients with isolated
retinal disease due to biallelic mutations in MFSD8, a gene
more usually associated with vLINCL. The data suggest a
genotype/phenotype relationship such that a mild reduction in
function results in an isolated later-onset maculopathy;
moderate reduction results in an earlier-onset generalized
rod-cone dystrophy; and much wider central nervous system
pathology if both alleles are functionally null. ERG demon-
strates additional dysfunction occurring after phototransduc-
tion in the cone system, and immunofluorescence localizes the
putative lysosomal transporter MFSD8 to the photoreceptor
presynaptic terminals in the retinal OPL. Together these
observations support a synaptic defect as the primary basis
of pathology for this type of vLINCL and related diseases.
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